172 related articles for article (PubMed ID: 21448647)
1. Possible anti-metastatic effect of iloprost in a patient with systemic sclerosis with lung cancer: a case study.
Pehlivan Y; Turkbeyler IH; Balakan O; Sevinc A; Yilmaz M; Bakir K; Onat AM
Rheumatol Int; 2012 May; 32(5):1437-41. PubMed ID: 21448647
[TBL] [Abstract][Full Text] [Related]
2. Sustained success of therapy with inhaled iloprost for severe pulmonary arterial hypertension associated with systemic sclerosis and pulmonary fibrosis.
Ahmadi-Simab K; Köhler A; Gross WL
Clin Exp Rheumatol; 2007; 25(5):760-2. PubMed ID: 18078629
[TBL] [Abstract][Full Text] [Related]
3. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
4. [Pulmonary arterial hypertension and systemic sclerosis].
Launay D; Humbert M; Hachulla E
Presse Med; 2006 Dec; 35(12 Pt 2):1929-37. PubMed ID: 17159719
[TBL] [Abstract][Full Text] [Related]
5. Successful therapy of bosentan-refractory pulmonary arterial hypertension (PAH) with inhalative iloprost.
Ahmadi-Simab K; Lamprecht P; Gross WL
Clin Exp Rheumatol; 2005; 23(3):402-3. PubMed ID: 15971433
[TBL] [Abstract][Full Text] [Related]
6. Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension.
Bourge RC; Tapson VF; Safdar Z; Benza RL; Channick RN; Rosenzweig EB; Shapiro S; White RJ; McSwain CS; Gotzkowsky SK; Nelsen AC; Rubin LJ
Cardiovasc Ther; 2013 Feb; 31(1):38-44. PubMed ID: 22970909
[TBL] [Abstract][Full Text] [Related]
7. Severe vascular complications in patients affected by systemic sclerosis cyclically treated with iloprost.
Caramaschi P; Dalla Gassa A; Prati D; Barausse G; Tinazzi I; Ravagnani V; Confente S; Biasi D
Rheumatol Int; 2012 Jul; 32(7):1933-8. PubMed ID: 21448643
[TBL] [Abstract][Full Text] [Related]
8. [Iloprost for the treatment of systemic sclerosis].
Hachulla E; Launay D; Hatron PY
Presse Med; 2008 May; 37(5 Pt 2):831-9. PubMed ID: 18035518
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of long-term oral monotherapy and additional effect of inhaled iloprost in patients with severe idiopathic pulmonary arterial hypertension].
Onen ZP; Sayın T; Akkoca Yıldız O; Ozdemir Kumbasar O; Karabıyıkoğlu G
Anadolu Kardiyol Derg; 2010 Oct; 10(5):458-60. PubMed ID: 20929705
[No Abstract] [Full Text] [Related]
10. Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension.
Hoeper MM; Spiekerkoetter E; Westerkamp V; Gatzke R; Fabel H
Eur Respir J; 2002 Aug; 20(2):339-43. PubMed ID: 12212965
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation.
Opitz CF; Wensel R; Bettmann M; Schaffarczyk R; Linscheid M; Hetzer R; Ewert R
Eur Heart J; 2003 Feb; 24(4):356-65. PubMed ID: 12581683
[TBL] [Abstract][Full Text] [Related]
12. Inhaled iloprost for the control of pulmonary hypertension.
Krug S; Sablotzki A; Hammerschmidt S; Wirtz H; Seyfarth HJ
Vasc Health Risk Manag; 2009; 5(1):465-74. PubMed ID: 19475782
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of adenosine versus iloprost by acute vasodilator test in patients of pulmonary arterial hypertension complicated with connective tissue diseases].
Tian Z; Chen TB; Fang Q; Zeng XF; Liu YT; Li MT; Jiang XC; Gao P; Cheng KA; Wang Q
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(30):2099-102. PubMed ID: 20058611
[TBL] [Abstract][Full Text] [Related]
14. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
[TBL] [Abstract][Full Text] [Related]
15. Iloprost inhalation solution for the treatment of pulmonary arterial hypertension.
Hsu HH; Rubin LJ
Expert Opin Pharmacother; 2005 Sep; 6(11):1921-30. PubMed ID: 16144511
[TBL] [Abstract][Full Text] [Related]
16. Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass.
Theodoraki K; Rellia P; Thanopoulos A; Tsourelis L; Zarkalis D; Sfyrakis P; Antoniou T
Can J Anaesth; 2002 Nov; 49(9):963-7. PubMed ID: 12419726
[TBL] [Abstract][Full Text] [Related]
17. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension].
Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W
Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363
[No Abstract] [Full Text] [Related]
18. Role of iloprost and bosentan in pulmonary arterial hypertension.
Saleh JA
Niger J Med; 2008; 17(1):13-9. PubMed ID: 18390125
[TBL] [Abstract][Full Text] [Related]
19. [Effect of nebulised iloprost combined with inhaled nitric oxide and oral sildenafil on lung transplant patients. Therapeutic efficacy in pulmonary hypertension during surgery].
Rabanal Llevot JM; Cimadevilla Calvo B; Cifrian Martinez JM; Ruisanchez Villar C; Mons Lera R
Rev Esp Anestesiol Reanim; 2012 Mar; 59(3):142-9. PubMed ID: 22985755
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years.
Bettoni L; Geri A; Airò P; Danieli E; Cavazzana I; Antonioli C; Chiesa L; Franceschini F; Grottolo A; Zambruni A; Radaeli E; Cattaneo R
Clin Rheumatol; 2002 Jun; 21(3):244-50. PubMed ID: 12111631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
